Background Current or recent use of combined oral contraceptives (containing oestrogen+
progestagen) has been associated with a small increase in breast cancer risk. Progestagen …

This review aims to summarize and assess key studies investigating the relationship
between hormonal contraception and breast cancer risk. Approximately two-thirds of breast …

Breast cancer survival has increased significantly over the last few decades due to more
effective strategies for prevention and risk modification, advancements in imaging detection …

Reproductive factors play significantly important roles in determining the breast cancer (BC)
risk. The impact of pregnancy, abortion, and birth control methods on tumor development …

Objectives Levonorgestrel intrauterine sustained release system (LNG-IUS) is an
intrauterine hormonal contraceptive device. Breast cancer (BC) was the most common type …

Non-coding RNA (ncRNAs) is greatly known to be involved in many cellular processes such
as growth and development including tumorigenesis. Alterations in expression of ncRNAs …

A key distinctive feature of breast tissue is its dependence on female sex steroid hormones,
which are responsible for epithelial cell proliferation and normal development of the …

Oral contraception was introduced almost 50-60 years ago. Now a huge number of the
female population use it as primary contraception across the globe as it is a convenient …

Background: Normal hypothalamic-pituitary-ovarian (HPO) endocrine function is essential
for female pubertal and psychosocial development and for ongoing adult physical, sexual …

Background The levonorgestrel-releasing intrauterine device (LNG-IUD) is widely used for
the treatment of menorrhagia, dysmenorrhea, and for contraception. However, the …